HLA typing for transplant market was valued at $1,211.3 million in 2025 and is projected to reach $2,196.80 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The global HLA typing for transplant market is shaped by the increasing number of organ and stem cell transplant procedures worldwide. Accurate HLA matching is essential to reduce the risk of transplant rejection and improve patient outcomes. Advances in molecular diagnostic techniques have improved the precision and efficiency of HLA typing methods. Hospitals, transplant centers, and diagnostic laboratories represent the primary users of these services. Demand is supported by ongoing needs for donor–recipient compatibility testing in clinical practice.
Browse the full report description of “HLA Typing for Transplant Market Size, Share & Trends Analysis Report By Type (Molecular Assays, and Non-Molecular Assays) By Product & Services (Reagents, Software, and Instruments) By Application (Diagnostics, and Research) By End-Users (Academic Institutes & Research Centers, Hospitals & Transplant Centers, and others) Forecast, (2026-2035)” Of https://www.omrglobal.com/industry-reports/hla-typing-transplant-market
Regional market trends vary based on transplant activity levels and healthcare infrastructure. North America and Europe account for a significant share due to established transplant programs and access to advanced laboratory technologies. In Asia-Pacific, market growth is supported by expanding healthcare services and increasing awareness of transplant procedures. Regulatory requirements and quality standards influence testing protocols and technology adoption. Overall, the market continues to develop in response to clinical demand, technological progress, and healthcare system capacity.
Innovation Leaders Transforming the Global HLA Typing for Transplant Market Research and Forecast
The key players in the global HLA typing for transplant market include Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd. (Roche), Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., among others. Companies are transforming the Global HLA Typing for Transplant Market by launching advanced genotyping kits, expanding high?resolution sequencing solutions, and introducing diagnostics that enhance donor?recipient compatibility assessment in clinical transplant workflows.
Market Coverage
Key questions addressed by the report.
Global HLA Typing for Transplant Market Research and Forecast Report Segment
By type
By products & services
By end users
Global HLA Typing for Transplant Market Research and Forecast Report Segment by Region
North America
Asia-Pacific
Europe
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hla-typing-transplant-market